ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

トフィソパム

Tofisopam

HCID 5502
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
22345-47-7
標準SMILES
CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21
InChIKey
RUJBDQSFYCKFAA-UHFFFAOYSA-N
分子式
C22H26N2O4
平均分子量
382.5 g/mol
単同位体質量
382.18925731

概要

Tofisopam is an organic molecular entity.

名称と識別子

優先名称
Tofisopam
IUPAC
1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
現地名
トフィソパム
英語名
TOFISOPAM
分子式
C22H26N2O4
分子量
382.45

名称と別名

tofisopam22345-47-71-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepineEmandaxintofizopamTofisopamumDTXSID3023681UZC80HAU42DTXCID303681RefChem:898544N05BA23(5RS)-1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
名称をさらに表示
トルバナシンツルベールトフィールトフィス1-(3,4-ジメトキシフェニル)-4-メチル-5-エチル-7,8-ジメトキシ-5H-2,3-ベンゾジアゼピンゲースベングランパムマイロニン1-(3,4-ジメトキシフェニル)-5-エチル-7,8-ジメトキシ-4-メチル-5H-2,3-ベンゾジアゼピントフィソパムトロンヘイムバイダキシングランダキシントフィルシンエマンダキシンクラソパンハイミジンコバンダキシン1-(3,4-ジメトキシフェニル)-5-エチル-7,8-ジメトキシ-4-メチル-5H-ベンゾ[d][1,2]ジアゼピントフィソパム (JP17)TosopamTofisopam, >=99%TOFISOPAM 22345-47-7Tofisopam, 10 mM in DMSO

物性

構造計算による物性

XLogP
3.2
極性表面積
61.6 Ų
水素結合供与体数
0
水素結合受容体数
6
回転可能結合数
6
重原子数
28
形式電荷
0
複雑度
579

実験および物理化学的性質

Melting Point152 °C
Physical DescriptionSolid

物理化学的性質

融点
155 · 155-159°C
沸点
509.61 °C · 509.61°C (rough estimate)
比重(密度)
1.2098 · 1.2098 (rough estimate)
屈折率
1.65 · 1.6500 (estimate)
溶解性
14 mg/mL · DMSO: ~14 mg/mL
外見
個体
酸解離定数(Pka)
7.29 · 7.29±0.40(Predicted)
色
白い
Merck
14 · 14,9503
安定性
Hygroscopic
InChI
1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3
InChIKey
RUJBDQSFYCKFAA-UHFFFAOYSA-N
SMILES
CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c3cc(OC)c(OC)cc13

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1 件

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 件

Like other benzodiazepines, tofisopam possesses anxiolytic properties but unlike other benzodiazepines it does not have anticonvulsant, sedative, skeletal muscle relaxant, motor skill-impairing or amnestic properties. It enhances the anticonvulsant activity of 1,4-benzodiazepines like diazepam but not sodium valproate, carbamazepine, phenobarbital, or phenytoin.

Mechanism of Action · 1 件

Tofisopam does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor. One study (Rundfeldt C. et al.) has shown that tofisopam acts as an isoenzyme-selective inhibitor of phosphodiesterases (PDEs) with highest affinity to PDE-4A1 (0.42 μM) followed by PDE-10A1 (0.92 μM), PDE-3 (1.98 μM) and PDE-2A3 (2.11 μM).

Biological Half-Life6-8 hours
Metabolism/Metabolites · 2 件

Hepatic.

Hepatic. Half Life: 6-8 hours

MeSH Pharmacological Classification · 1 件

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Cellular LocationsMembrane

用途と製造

関連反応

7 件
反応記録を作成
HRID 905168 の反応式
HRID 905168反応物としてuspto-grants-1983_12
HRID 905169 の反応式
HRID 905169反応物としてuspto-grants-1983_12
HRID 1146474 の反応式
HRID 1146474反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (7/10)
HRID 1149226 の反応式
HRID 1149226反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (7/10)
HRID 1235106 の反応式
HRID 1235106反応物としてTraining data from https://doi.org/10.1039/C8SC04228D (5/10)
HRID 1421857 の反応式
HRID 1421857生成物としてuspto-grants-2000_06
HRID 2059130 の反応式
HRID 2059130反応物としてuspto-grants-1982_03

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
7-CHLORO-1-METHYL-5-PHENYL-1,5-BENZODIAZEPINE-2,4-DIONE
244-922-3GrandaxinEgyt 341MFCD008231715H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepineNCGC00165912-02Seriel

データベース識別子

CAS
22345-47-7
PubChem CID
5502
DTXSID
DTXSID3023681
ChEMBL
CHEMBL404216
ChEBI
CHEBI:32241
UNII
UZC80HAU42
EC Number
244-922-3
Nikkaji
J11.504E

Tofisopam does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor. One study (Rundfeldt C. et al.) has shown that tofisopam acts as an isoenzyme-selective inhibitor of phosphodiesterases (PDEs) with highest affinity to PDE-4A1 (0.42 _Мц_M) followed by PDE-10A1 (0.92 _Мц_M), PDE-3 (1.98 _Мц_M) and PDE-2A3 (2.11 _Мц_M).

Signs and Symptoms · 1 件

The onset of impairment of consciousness is relatively rapid in benzodiazepine poisoning. Onset is more rapid following larger doses and with agents of shorter duration of action. The most common and initial symptom is somnolence. This may progress to coma (Grade I or Grade II) following very large ingestions.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataOral, Rat: LD50 = 825 mg/kg.

安全データ

wgk
2
rtecs
DE9540000
ridadr
UN 3077 9/PG 3
hs_code
2933.99.8290
risk_code
22-50
hazard_code
Xn,N
safety_code
60-61
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1
ストレージクラス
11 - Combustible Solids
Uses
For the treatment of anxiety and alcohol withdrawal.

応用分野

用途ベンゾジアゼピン系化合物で す。GABA 受容体に作用し、中枢神経抑制作 用を示します。作用時間は、短時間型とされ ています。

用途ベンゾジアゼピン系化合物で す。GABA受容体に作用し、中枢神経抑制作 用を示します。作用時間は、短時間型とされ ています。

上流・下流製品情報

上流原料

ヒドラジン一水和物

サプライヤー74 社

阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
咸宁深蓝生物医药研发有限公司18171815831 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
陕西缔都新材料有限公司029-63373950 17392216152 · [email protected]
湖北科乐精细化工有限公司027-59101668 19945030958 · [email protected]
上海仲因实业有限公司2537653158 16621191650 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
上海波以尔化工有限公司[email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
广东云星生物技术有限公司0751-18902340975/189023400307 18902340307 · [email protected]
Cangzhou Wanyou New Material Technology Co.,Ltd18631714998 · [email protected]
杭州迈可医药科技有限公司189-05714267 · [email protected]
United Life Science020-82099279 18988968278 · [email protected]
InvivoChem中国13549236410 · [email protected]
常州市华阳科技有限公司+8615250961469 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
杭州东帆化学有限公司86-0571-85151182
合肥朝博科技有限公司19322001459
Wuhan NCE Biomedical Co.,Ltd.4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
上海遐瑞医药科技有限公司+86 21 61551611
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
上海诺宝化工有限公司+86(0)21 60484900
金瓯生物医药(南京)有限公司13000000000 · [email protected]
上海旺瑜生物科技有限公司021-59501308 18321645636 · [email protected]
无锡中坤生化科技有限公司+86 0510-85629785
上海昶衍化工科技有限公司021-20242659 18930833303 · [email protected]
北京阳光福润科技有限公司010-57495520 13521095525 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
杭州杰恒化工有限公司0571-87396432 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
石家庄通洋进出口有限公司[email protected]
江苏倍达医药科技有限公司0512-63009836 18994340901 · [email protected]
上海超岚化工科技中心(原宁波市超明生物科技有限公司)13301662590 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
武汉多普乐生物医药有限公司+86-02787215551 19945035818 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
武汉沃格达生物科技有限公司15071299552 · [email protected]
BOC Sciences[email protected]
Shanghai Acmec Biochemical Technology Co., Ltd.+86-18621343501 · [email protected]
杭州洁汉化工有限公司+86-571-86217390; +8618058761490 · [email protected]
无锡鸣鹭医药科技有限公司0510-88726693 · [email protected]
江苏艾康生物医药研发有限公司025-58851090 13913916777 · [email protected]
南京法恩化学有限公司025-85710122 17714198479 · [email protected]
艾览(上海)化工科技有限公司400-668-9898 · [email protected]
上海凯裕医药科技有限公司17317130613 · [email protected]
上海宏叶生物科技有限公司400-9205774 400-920-5774 · [email protected]